Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Giuliani S P A currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units. This 1 to 1 ratio of actions to both examiners and art units indicates a diversified prosecution path for the company's active matters. The company's biotech filings are being reviewed in different specialized environments within the patent office.
The busiest examiner is PROSSER, ALISSA J, who is responsible for 1 busiest examiner pending office action. This 1 action represents 1 of the 2 pending office actions for the company. With 2 distinct examiners and 2 distinct art units involved, the company is receiving feedback from multiple reviewers. This variety can lead to different examination experiences even with a small number of active cases, as each matter is being handled by a unique combination of examiner and art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PROSSER, ALISSA J | 1 | 15.7% | +11.2% |
| WEBB, WALTER E | 1 | 46.3% | +18.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18868112 | DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES | PROSSER, ALISSA J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18868112 | DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES | PROSSER, ALISSA J | — |
| 18718625 | Cosmetic Composition For Restructuring Hair And Improving The Appearance Thereof | WEBB, WALTER E | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18868112 | DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES | PROSSER, ALISSA J | 1619 | §103DP | Final Rejection | — | Pending | Nov 21, 2024 |
| 18718625 | Cosmetic Composition For Restructuring Hair And Improving The Appearance Thereof | WEBB, WALTER E | 1612 | DP | Final Rejection | — | Pending | Jun 11, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial